About 1 result found for searched term "Tiragolumab" (0.13 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24851 | Tiragolumab | TIGIT |
| Tiragolumab is an immune checkpoint inhibitor that binds to T-cell immunoglobulin and the structural domain of ITIM (TIGIT), targets TIGIT and has an intact Fc region. Tiragolumab is indicated for use in studies related to solid tumors. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
